Model Innovation: Independently design, engineer, validate, and optimize disease-relevant cellular models at scale to enable phenotypic screening and small molecule drug discovery.
Advanced Engineering: Apply diverse cell engineering approaches, including CRISPR/Cas technologies, vector design, reporter systems, and stable cell line generation, to build robust assay systems.
Pipeline Integration: Translate complex cellular models into scalable, reproducible, screening-compatible workflows for high-content imaging and phenotypic screening.
Cross-Functional Collaboration: Partner actively across therapeutic areas, automation, data analysis, and chemistry teams to interpret results, present data, and support project decisions.
Culture Contribution: Actively cultivate an inclusive, collaborative, and curious team environment focused on pushing scientific boundaries.